Ventolin hfa and Uptravi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ventolin hfa (albuterol sulfate) and Uptravi (selexipag). Common drug interactions include pneumonia among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Ventolin hfa and Uptravi. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Ventolin hfa?

Ventolin hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 40,061 Ventolin hfa users. Check the latest studies of Ventolin hfa.

What is Uptravi?

Uptravi has active ingredients of selexipag. eHealthMe is studying from 26,576 Uptravi users. Check the latest studies of Uptravi.



On Jul, 05, 2026

76 people who take Ventolin hfa and Uptravi together, and have interactions are studied.

Ventolin hfa and Uptravi drug interactions.

What are the common drug interactions of Ventolin Hfa and Uptravi, by gender? *:

female:

  1. Pneumonia
  2. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  3. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  4. Fluid overload (too much fluid in the blood)
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Cardiac failure
  7. Hypotension (abnormally low blood pressure)
  8. Pulmonary arterial pressure increased
  9. Pulmonary oedema (fluid accumulation in the lungs)
  10. Seasonal allergy (allergic condition due to certain season)

male:

  1. Dizziness
  2. Nausea (feeling of having an urge to vomit)
  3. Back pain
  4. Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
  5. Constipation
  6. Depressed mood
  7. Fluid retention (an abnormal accumulation of fluid in the blood)
  8. General physical health deterioration (weak health status)
  9. Hyperhidrosis (abnormally increased sweating)
  10. Pain in extremity

What are the common drug interactions of Ventolin Hfa and Uptravi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Chest discomfort
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Non-cardiac chest pain
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Nausea (feeling of having an urge to vomit)
  7. Pain in jaw

20-29:

n/a

30-39:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

40-49:

  1. Cardiac failure congestive
  2. Arthralgia (joint pain)
  3. Blood glucose decreased
  4. Herpes zoster
  5. Hypoglycaemia (deficiency of glucose in the bloodstream)
  6. Pain in extremity
  7. Pain in jaw
  8. Anaemia (lack of blood)
  9. Dehydration (dryness resulting from the removal of water)
  10. Fluid overload (too much fluid in the blood)

50-59:

  1. Diarrhoea
  2. Dizziness
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Presyncope
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Abdominal discomfort
  7. Back pain
  8. Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
  9. Constipation
  10. Depressed mood

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhoea
  3. Blood pressure decreased
  4. Influenza like illness
  5. Fatigue (feeling of tiredness)
  6. Pulmonary hypertension (increase in blood pressure in the lung artery)
  7. Hip arthroplasty
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  10. Pain in extremity

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 53 people, 69.74%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 24 people, 31.58%
  3. Pain: 7 people, 9.21%
  4. Wheezing (a high-pitched whistling sound made while you breath): 5 people, 6.58%
  5. Type 2 Diabetes: 4 people, 5.26%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 5.26%
  7. Cough: 4 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin hfa and Uptravi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ventolin hfa and Uptravi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ventolin hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Uptravi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ventolin hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Uptravi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate and selexipag (the active ingredients of Ventolin hfa and Uptravi, respectively), and Ventolin hfa and Uptravi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: